Price $27.51 |
Market Cap
568.9M
|
Sector Health Care |
Div. Growth
26.20%
|
|
P/E
26.0
|
P/B
4.37
|
P/S
5.39
|
Dividend %
1.20%
|
|
P/CF
81.0
|
P/FCF
42.8
|
Op. Cash Flow
19.5K
|
FCF
0.6
|
|
Op. Margin
26.80%
|
Net Margin
21.70%
|
ROE
18.70%
|
ROI
17.10%
|
|
ROA
16.30%
|
EPS Growth
30.50%
|
Current Ratio
4.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Celsion Corporation (CLSN) | $2.14 | - | - | 44.4M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.63 | - | - | 16.59B | Strong Buy |
| Natus Medical Inc (BABY) | $26.35 | - | - | 855.4M | Strong Buy |
| TearLab Corp (TEAR) | $0.09 | - | - | 1M | Strong Buy |
| CYANOTECH CORP (CYAN) | $3.15 | - | - | 19.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
